Insider · CIK 0001448914
Michael Thomas Heffernan
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC), AVTX (Avalo Therapeutics, Inc.), TRVI (Trevi Therapeutics, Inc.), BHVN (Biohaven Ltd.), ENGN (enGene Holdings Inc.). First filing Sep 17, 2026, latest Sep 17, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TRVI: Trevi Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | Trevi Therapeutics, Inc. | $596k 39,473 shares | -159% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +18,421 | $3.04 | $56k | 24,772 | 25 d ago |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -18,321 | $15.09 | $276k | 6,451 | 25 d ago |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $15.88 | $1,588 | 6,351 | 25 d ago |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +21,052 | $3.33 | $70k | 27,403 | 25 d ago |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -20,952 | $15.09 | $316k | 6,451 | 25 d ago |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $15.88 | $1,588 | 6,351 | 25 d ago |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -18,421 | $0.00 | $0 | 0 | 25 d ago |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -21,052 | $0.00 | $0 | 0 | 25 d ago |
| Jul 8, 2025 | ENGN enGene Holdings Inc. | AGrant or award Stock Option (Right to Buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jul 10, 2025 |
| Jun 17, 2025 | AVTX Avalo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +29,500 | $0.00 | $0 | 29,500 | Jun 18, 2025 |
| Jun 11, 2025 | TRVI Trevi Therapeutics, Inc. | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jun 13, 2025 |
| May 5, 2025 | BHVN Biohaven Ltd. | AGrant or award Stock Options (Right to buy)derivative | +31,716 | $0.00 | $0 | 31,716 | May 7, 2025 |
| Mar 25, 2025 | AVTX Avalo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Mar 26, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +4,820 | $0.00 | $0 | 50,328 | Feb 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.